Cromolyn sodium Inh Soln Rx
Generic Name and Formulations:
Cromolyn sodium 20mg/2mL; soln for inhalation.
Various generic manufacturers
Indications for Cromolyn sodium Inh Soln:
Asthma prophylaxis. Prevention of bronchoconstriction before exposure to a known precipitant (eg, exercise).
Adults and Children:
<2 years: not recommended. ≥2 years: 20mg administered by power-operated nebulizer 4 times a day. Bronchoconstriction prevention: contents of 1 amp inhaled up to 60 minutes before precipitant.
Not for treatment of acute attack. Impaired renal or hepatic function: reduce dose. Reevaluate if no improvement after 4 weeks. Avoid abrupt cessation. Discontinue if eosinophilic pneumonia occurs. Coronary artery disease or arrhythmias (Inhaler). Pregnancy (Cat.B). Nursing mothers.
Avoid use with isoproterenol during pregnancy.
Mast cell stabilizer.
Bronchospasm, throat irritation, bad taste, cough, wheezing, nasal congestion, anaphylaxis.
Formerly known under the brand name Intal.
Endocrinology Advisor Articles
- Single Blood Sample Highly Predictive for Subsequent Diabetes Diagnosis
- Adjunctive Metformin for Insulin Resistance in T1D: A Clinical Perspective
- Effect of Fructose, Allulose on Postprandial Glucose Regulation in Type 2 Diabetes
- Sex Hormone Levels May Affect Postmenopausal Heart Disease Risk
- Menopausal Hormone Therapy Slows Cognitive Decline in Postmenopausal Women
- Diabetes Treatments
- Metformin May Decrease Colorectal Cancer Risk Among Males With Diabetes
- SGLT2 Inhibitor, GLP-1 Receptor Agonist Combination Treatment for Type 2 Diabetes: Expert Insights
- Semaglutide May Induce Weight Loss in Type 2 Diabetes Despite BMI
- FDA Clears Omnipod DASH System for Diabetes Management
- Effect of Infant Feeding Practices and Gut Microbiota on Overweight in First Year
- Empagliflozin, Linagliptin Combination Therapy vs Linagliptin Monotherapy for Type 2 Diabetes
- Cleared Blood Glucose Monitor Systems Not Always Accurate
- CDC: Obesity Prevalence Higher in Non-Metropolitan Counties
- Vascular Mortality Declining in Adults With Diabetes in the United States